NCT01372540
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Leukemia, Plasma Cell
Explore clinical trials studying Leukemia, Plasma Cell. Study availability and eligibility vary by location and protocol.
48 public trials
23 recruiting studies
Leukemia, Plasma Cell trial results
- Conditions
- B-Cell Prolymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +51 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT00307086
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT01553357
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- IRCCS - CROB Ethic Committee Rionero in Vulture, Pz, Italy
Active, Not Recruiting
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia
NCT05870917
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China
Active, Not Recruiting
SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
NCT02334865
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- University of Rochester Medical Center Rochester, New York, United States
Active, Not Recruiting
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT03389347
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
NCT05823571
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, CML, +34 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States